CHU Timone

May 13, 2024 | link.springer.com | Institut de neurophysiopathologie |CHU Timone |Charles Champeaux |Hôpital Privé Clairval

AbstractMeningioma is one of the most common neoplasm of the central nervous system. To describe the epidemiology of meningioma operated in France and, to assess grading and histopathological variability among the different neurosurgical centres. We processed the French Brain Tumour Database (FBTDB) to conduct a nationwide population-based study of all histopathologically confirmed meningiomas between 2006 and 2015. 30,223 meningiomas cases were operated on 28,424 patients, in 61 centres.

Jun 18, 2023 | frontiersin.org | CHU Timone

Victor Morel1 AUDIC Frédérique2, 3 Charlotte Tardy1 Annie Verschueren4 Shahram Attarian3, 4 Karine Nguyen1, 3 Emmanuelle Salort-campana3, 4 Martin Krahn1, 3 Brigitte Chabrol2, 3 Svetlana Gorokhova1, 3* 1Département de Génétique Médicale, Hôpital de la Timone, France 2Service de Neuropédiatrie, Centre de Référence des Maladies Neuromusculaires de l'enfant PACARARE, CHU Timone, APHM, France 3INSERM U1251 Centre de Génétique Médicale de Marseille (MMG), France 4Centre de référence des Maladies...

Mar 8, 2023 | link.springer.com | Aix Marseille |CHU Timone

AbstractIn the era of effective therapies in melanoma, notably the widespread use of two types of adjuvant treatments: anti-PD-1 immunotherapies and therapies targeting the mitogen-activated protein kinase pathway, for BRAF-mutant patients, an important question arises about how to treat these patients in case of recurrent melanoma following adjuvant therapy. Prospective data are lacking in this area and might be difficult to obtain due to the constant progress being made in the field.